Recently, Qiu et al. have shown that CCAT2 was highly expressed in NSCLC, especially in LAD and silencing CCAT2 by siRNA could inhibit the proliferation and invasion of NSCLC cell lines in vitro [60]. The gene discussed is CCAT2; the disease is non-small cell lung carcinoma.